IXICO PLC
IXICO plc provides data analytics services to biopharmaceutical industry in the United States, the United Kingdom, the Netherlands, Denmark, Switzerland, Ireland, Europe, and internationally. The company offers collection, analysis, management, and reporting on gathered clinical study data; neurological diseases data collection and analysis; and sales and marketing services. It also provides imag… Read more
IXICO PLC - Asset Resilience Ratio
IXICO PLC (IXI) has an Asset Resilience Ratio of 1.79% as of March 2014. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2000–2013)
This chart shows how IXICO PLC's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down IXICO PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 0% |
| Short-term Investments | GBX104.00K | 1.79% |
| Total Liquid Assets | GBX104.00K | 1.79% |
Asset Resilience Insights
- Limited Liquidity: IXICO PLC maintains only 1.79% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
IXICO PLC Industry Peers by Asset Resilience Ratio
Compare IXICO PLC's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
MedPacto Inc
KQ:235980 |
Biotechnology | 49.82% |
|
Shenzhen CAU Technology Co Ltd
SHE:000004 |
Biotechnology | 6.20% |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403 |
Biotechnology | 6.88% |
|
Nanhua Bio Medicine Co Ltd
SHE:000504 |
Biotechnology | 11.93% |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518 |
Biotechnology | 0.03% |
|
Chengzhi Shareholding Co Ltd
SHE:000990 |
Biotechnology | 6.73% |
|
Hualan Biological EngineeringInc
SHE:002007 |
Biotechnology | 14.68% |
|
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030 |
Biotechnology | 4.35% |
Annual Asset Resilience Ratio for IXICO PLC (2000–2013)
The table below shows the annual Asset Resilience Ratio data for IXICO PLC.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2013-09-30 | 2.00% | GBX103.00K | GBX5.15 Million | -79.22pp |
| 2012-09-30 | 81.22% | GBX8.60 Million | GBX10.59 Million | +3.25pp |
| 2011-09-30 | 77.97% | GBX14.50 Million | GBX18.60 Million | -13.45pp |
| 2010-09-30 | 91.42% | GBX22.50 Million | GBX24.61 Million | +26.66pp |
| 2008-09-30 | 64.75% | GBX5.50 Million | GBX8.49 Million | -4.60pp |
| 2004-08-31 | 69.36% | GBX5.24 Million | GBX7.55 Million | -4.88pp |
| 2003-08-31 | 74.23% | GBX5.13 Million | GBX6.91 Million | +2.07pp |
| 2002-08-31 | 72.16% | GBX8.83 Million | GBX12.24 Million | -17.26pp |
| 2001-08-31 | 89.42% | GBX12.67 Million | GBX14.17 Million | +10.12pp |
| 2000-08-31 | 79.30% | GBX4.53 Million | GBX5.71 Million | -- |